We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current 4BB market cap is 121.35M. The company's latest EPS is GBP -1.0011 and P/E is -9.84.
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 567k | 421k | 335k | 984k | 1.46M |
| Operating Income | -1.09M | -3.2M | -4.9M | -7.48M | -12.79M |
| Net Income | -719k | -3.24M | -5.15M | -7.67M | -12.33M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 17.81M | 14.7M | 11.69M | 11.92M | 44.73M |
| Total Liabilities | 2.35M | 3.01M | 4.57M | 12.41M | 18.35M |
| Total Equity | 15.46M | 11.7M | 7.12M | -492k | 26.38M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.02M | -2.74M | -4.7M | -6.18M | -10.74M |
| Investing | 1.45M | -1.51M | -1.94M | -1.49M | -1.57M |
| Financing | 14.43M | -467k | 1.24M | 6.43M | 43.87M |
| Market Cap | 121.35M |
| Price to Earnings Ratio | -9.84 |
| Price to Sales Ratio | 83.4 |
| Price to Cash Ratio | 3.51 |
| Price to Book Ratio | 4.6 |
| Dividend Yield | - |
| Shares Outstanding | 12.32M |
| Average Volume (1 week) | 2.13k |
| Average Volume (1 Month) | 822 |
| 52 Week Change | -43.87% |
| 52 Week High | 1,820.00 |
| 52 Week Low | 985.00 |
| Spread (Intraday) | 50 (4.95%) |
| Company Name | 4basebio Plc |
| Address |
25 norman way cambridgeshire CB24 5QE |
| Website | https://www.4basebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
